These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17301484)

  • 21. Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
    Chang WS; Kim JY; Kim YJ; Kim YS; Lee JM; Azuma M; Yagita H; Kang CY
    J Immunol; 2008 Nov; 181(10):6707-10. PubMed ID: 18981087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
    Liu Y; Yu Y; Yang S; Zeng B; Zhang Z; Jiao G; Zhang Y; Cai L; Yang R
    Cancer Immunol Immunother; 2009 May; 58(5):687-97. PubMed ID: 18828017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
    Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
    Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
    Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
    J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N; Wang YH; Yagita H; Dong C
    J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.
    Zhou Q; Munger ME; Highfill SL; Tolar J; Weigel BJ; Riddle M; Sharpe AH; Vallera DA; Azuma M; Levine BL; June CH; Murphy WJ; Munn DH; Blazar BR
    Blood; 2010 Oct; 116(14):2484-93. PubMed ID: 20570856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation.
    Talay O; Shen CH; Chen L; Chen J
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2741-6. PubMed ID: 19202065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
    Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy.
    Alderson KL; Zhou Q; Berner V; Wilkins DE; Weiss JM; Blazar BR; Welniak LA; Wiltrout RH; Redelman D; Murphy WJ
    J Immunol; 2008 Mar; 180(5):2981-8. PubMed ID: 18292520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.
    Joshi T; Rodriguez S; Perovic V; Cockburn IA; Stäger S
    PLoS Pathog; 2009 May; 5(5):e1000431. PubMed ID: 19436710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.
    Hamel KM; Cao Y; Wang Y; Rodeghero R; Kobezda T; Chen L; Finnegan A
    Eur J Immunol; 2010 Nov; 40(11):3117-27. PubMed ID: 21061440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
    Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
    J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection.
    Seo SK; Jeong HY; Park SG; Lee SW; Choi IW; Chen L; Choi I
    Immunology; 2008 Jan; 123(1):90-9. PubMed ID: 17971153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
    Goldberg MV; Maris CH; Hipkiss EL; Flies AS; Zhen L; Tuder RM; Grosso JF; Harris TJ; Getnet D; Whartenby KA; Brockstedt DG; Dubensky TW; Chen L; Pardoll DM; Drake CG
    Blood; 2007 Jul; 110(1):186-92. PubMed ID: 17392506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.
    Diana J; Brezar V; Beaudoin L; Dalod M; Mellor A; Tafuri A; von Herrath M; Boitard C; Mallone R; Lehuen A
    J Exp Med; 2011 Apr; 208(4):729-45. PubMed ID: 21444661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.